We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$153M
AUM Growth
-$4.57M
Cap. Flow
-$15.9M
Cap. Flow %
-10.33%
Top 10 Hldgs %
51.2%
Holding
67
New
18
Increased
4
Reduced
14
Closed
25

Top Buys

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$5.94M
2
BVS icon
Bioventus
BVS
+$627K

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$5.35M
2
LIVN icon
LivaNova
LIVN
+$4.3M
3
ISRG icon
Intuitive Surgical
ISRG
+$4.05M
4
MASI
Masimo
MASI
+$3.15M
5
NTRA icon
Natera
NTRA
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 32.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSOS icon
1
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
$11.6M 7.58%
1,623,100
+836,100
+106% +$5.94M
IHI icon
2
PUT
iShares US Medical Devices ETF
IHI
$3.38B
$8.88M 5.79%
+150,000
New +$8.57M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$83B
$8.84M 5.76%
+40,000
New +$8.56M
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$8.61M 5.61%
15,000
-10,000
-40% -$5.53M
ESTA icon
5
Establishment Labs
ESTA
$2.28B
$8.31M 5.41%
191,939
-38,154
-17% -$1.66M
QQQ icon
6
PUT
Invesco QQQ Trust
QQQ
$484B
$7.32M 4.77%
15,000
-5,000
-25% -$2.37M
COO icon
7
CALL
Cooper Companies
COO
$14.5B
$6.62M 4.31%
60,000
+30,000
+100% +$2.92M
INSP icon
8
CALL
Inspire Medical Systems
INSP
$1.74B
$6.33M 4.13%
+30,000
New +$5.21M
WAT icon
9
PUT
Waters Corp
WAT
$39.9B
$6.3M 4.1%
+17,500
New +$5.7M
GKOS icon
10
Glaukos
GKOS
$10.6B
$5.73M 3.74%
44,000
-43,000
-49% -$5.35M
NTRA icon
11
Natera
NTRA
$46.1B
$5.52M 3.6%
43,500
-24,000
-36% -$2.76M
ISRG icon
12
Intuitive Surgical
ISRG
$134B
$5.01M 3.27%
10,200
-8,700
-46% -$4.05M
XBI icon
13
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$4.94M 3.22%
+50,000
New +$4.91M
ZBH icon
14
PUT
Zimmer Biomet
ZBH
$18.4B
$4.86M 3.17%
+45,000
New +$4.91M
QTRX icon
15
Quanterix
QTRX
$190M
$4.55M 2.96%
350,701
-58,633
-14% -$783K
LUNG icon
16
Pulmonx
LUNG
$87.6M
$4.23M 2.75%
509,775
-3,189
-0.6% -$23.1K
BVS icon
17
Bioventus
BVS
$1.19B
$4.21M 2.75%
352,569
+72,569
+26% +$627K
ICUI icon
18
ICU Medical
ICUI
$4.61B
$4.1M 2.67%
22,500
-6,834
-23% -$1.01M
ZTS icon
19
PUT
Zoetis
ZTS
$30.5B
$3.91M 2.55%
+20,000
New +$3.69M
MDT icon
20
PUT
Medtronic
MDT
$112B
$3.6M 2.35%
40,000
+10,000
+33% +$841K
SYK icon
21
PUT
Stryker
SYK
$130B
$3.25M 2.12%
+9,000
New +$3.11M
ICUI icon
22
CALL
ICU Medical
ICUI
$4.61B
$2.73M 1.78%
+15,000
New +$2.22M
LLY icon
23
PUT
Eli Lilly
LLY
$1.06T
$2.66M 1.73%
+3,000
New +$2.7M
GH icon
24
PUT
Guardant Health
GH
$22.6B
$2.64M 1.72%
+115,000
New +$3.25M
PRCT icon
25
PUT
Procept Biorobotics
PRCT
$1.17B
$2M 1.31%
+25,000
New +$1.78M

Similar funds

Pura Vida Investments's Q3 2024 Portfolio in Review

As of Q3 2024, Pura Vida Investments held 67 positions worth $153M, down 2.9% from $158M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Pura Vida Investments withdrew a net $15.9M in Q3 2024, closing 25 positions and reducing 14 holdings. Its most notable exit was LivaNova, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 49% a quarter earlier.

Against the trend, Pura Vida Investments added an estimated $5.94M to AdvisorShares Pure US Cannabis ETF.

  • Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q3 2024, an estimated $5.94M increase.
  • Pura Vida Investments's biggest Q3 2024 reduction was Glaukos, cutting an estimated $5.35M.
  • Pura Vida Investments fully exited LivaNova in Q3 2024, selling an estimated $4.3M.
  • Pura Vida Investments's ten largest holdings make up 51% of its $153M portfolio in Q3 2024.
  • Pura Vida Investments opened 18 new positions and closed 25 in Q3 2024.
  • Pura Vida Investments's portfolio value fell 2.9% quarter-over-quarter to $153M.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.